Work

Abstract A2: Targeting intracellular VEGF using nanotechnology for subcellular delivery of bevacizumab improves efficacy of combination therapy against pancreatic cancer

Year: 2009
Type: conference-abstract
Language: English
Open Access status: closed
OpenAlex ID: W1994401471
Cites:
Cited by: 1
Related to: 10